Systematic Review of Left Ventricular Remodeling in Response to Hypoglycemic Medications: Assessing Changes in End-Systolic and End-Diastolic Diameters.
低血糖藥物對左心室重塑的系統性回顧:評估心臟收縮末期和舒張末期直徑的變化。
Biomedicines 2024-08-29
Effects of new hypoglycemic drugs on cardiac remodeling: a systematic review and network meta-analysis.
新降血糖藥物對心臟重塑的影響:系統性回顧與網絡荟萃分析。
BMC Cardiovasc Disord 2023-11-20
Left ventricular mass predicts cardiac reverse remodelling in patients treated with empagliflozin.
左心室質量可預測接受 empagliflozin 治療的患者心臟逆轉重塑。
Cardiovasc Diabetol 2023-07-13
Left ventricular remodeling response to SGLT2 inhibitors in heart failure: an updated meta-analysis of randomized controlled studies.
SGLT2抑制劑在心力衰竭中左心室重塑反應:一項更新的隨機對照研究的荟萃分析。
Cardiovasc Diabetol 2023-11-21
The effect of sodium-glucose cotransporter 2 inhibitors on left cardiac remodelling in heart failure with reduced ejection fraction: Systematic review and meta-analysis.
SGLT-2 抑制劑對收縮功能減弱心衰左心臟重塑的影響:系統性回顧與荟萃分析。
Eur J Heart Fail 2024-03-27
Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials.
糖尿病患者中利拉魯肽對心臟功能的影響:雙盲、隨機、安慰劑對照試驗的系統性回顧和荟萃分析。
Medicine (Baltimore) 2024-03-18
The effect of glucagon-like peptide-1 receptor agonists on cardiac function and structure in patients with or without type 2 diabetes mellitus: An updated systematic review and meta-analysis.
GLP-1受體激動劑對有或無第2型糖尿病患者心臟功能和結構的影響:最新系統性回顧和荟萃分析。
Diabetes Obes Metab 2024-05-08
Impact of SGLT2 inhibition on markers of reverse cardiac remodelling in heart failure: Systematic review and meta-analysis.
SGLT2 抑制對心衰竭中逆向心臟重塑標記的影響:系統性回顧與統合分析。
ESC Heart Fail 2024-07-26
Examining the Impact of Ertugliflozin on Cardiovascular Outcomes in Patients with Diabetes and Metabolic Syndrome: A Systematic Review of Clinical Trials.
檢視Ertugliflozin對糖尿病及代謝症候群患者心血管結果的影響:一項臨床試驗的系統性回顧。
Pharmaceuticals (Basel) 2024-07-27
The effects of SGLT-2 inhibitors on echocardiographic indices and antioxidative properties in patients with heart failure with reduced ejection fraction and diabetes mellitus.
SGLT-2 抑制劑對於心臟射出分數降低及糖尿病患者的超聲心動圖指標和抗氧化特性的影響。
Eur Rev Med Pharmacol Sci 2024-09-04